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1. Introduction 
The 2-oxoacid (pyruvate or 2-oxoglutarate) dehy- 
drogenase complexes are composed of a lipoate acetyl- 
transferase (E2) core to which multiple copies of a 
2-oxoacid dehydrogenase (El) and lipoamide dehy- 
drogenase (E3) are bound (reviewed [ 1,2]). Recently, 
the molecular structure of the lipoate acetyltransferase 
component of bovine PDC has been elucidated by 
studies using limited proteolysis [3-S]. The acetyl- 
transferase polypeptide chain is built from two sepa- 
rate folding domains, one containing the active center 
for transacylation as well as the E2 intersubunit bind- 
ing sites (active domain) whereas the other comprises 
the enzyme-bound lipoyl residues (lipoyl domain). 
Little is known as yet on the structural properties of 
E2 from mammalian OGDC. This paper presents evi- 
dence indicating an analogous structural organization 
of mammalian OGDCE2 as found for PDCE2. 
2. Experimental 
2.1. Enzymes 
OGDC was purified from bovine kidney mitochon- 
dria according to [6]. The isolation procedure was 
modified by the addition of a sucrose density gradient 
centrifugation step as in [7]. The complex had spec. 
act. 8-12 U/mg. PDC activity in these preparations 
was 51% of OGDC. Glutamate dehydrogenase, succi- 
nate dehydrogenase, aspartate aminotransferase, and 
alanine aminotransferase activities were not detectable. 
The SDS gel electrophoresis pattern (fig.2) showed 
Abbreviations: PDC., pyruvate dehydrogenase complex; 
OGDC, 2oxoglutarate dehydrogenase complex; SDS, sodium 
dodecylsulfate; Mr, relative molecular mass 
the 4 principal bands described in [8] together with 
varying amounts of contaminating material most of 
which probably resulted from degradation by endog- 
enous proteases [8]. Estimated M, of the principal 
bands was: band 1 (El), 96 000; band 2 (unknown 
[8]), 90 000; band 3 (E3), 55 000; band 4 (E2), 
52 000. 
Papain, stem bromelain, and elastase were from 
Boehringer (Mannheim), trypsin (treated with Ltosyl- 
amido-2-phenylethyl chloromethyl ketone) from E. 
Merck (Darmstadt). PDC inactivase was a generous 
gift of Dr A. Lynen, Institut fur Diabetesforschung, 
Miinchen. The sources of all other materials were as 
in [3,4,7]. 
2.2. Enzyme assays 
OGDC overall activity (NAD reduction) and E3 
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Fig.1. Effect of PDC-inactivase treatment on the overall and 
component activities of OGDC. OGDC (0.5 mg/ml) was incu- 
bated at 23°C with PDC inactivase (4.8 pg/ml) in 0.1 M 
potassium phosphate (pH 6.5) 2 mM cysteine hydrochloride, 
1 mM EDTA. At the times indicated, samples were removed, 
mixed with leupeptin (0.14 mg/ml) and assayed. Overall 
activity (a); El (w); E2 (0); E3 (A); control sample containing 
0.1 mg leupeptin/ml, overall activity (0). 
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were assayed as in [7]. 2-Oxoglutarate dehydrogenase 
(El) was assayed either spectrophotometrically as in 
[9] or by measuring the decarboxylation of [l-14C]- 
oxoglutarate (NEN) under the conditions given in [lo]. 
Lipoate succinyltransferase (E2) was assayed accord- 
ing to [S]. With all assays, 1 U corresponds to 1 pmol 
product formed or substrate consumed/min at 25°C. 
overall activity of OGDC was destroyed by proteases 
such as rat liver lysosomal PDC inactivase [ 131 (fig. I), 
papain, elastase, or bromelain (not shown) without 
any loss of El, E2, or E3 activities. 
2.3. Treatment with proteases 
The experimental conditions for protease treatment 
of OGDC were identical as described for PDC in [3,7]. 
2.4. SDS gel electrophoresis 
Electrophoresis was carried out either in cylindrical 
gels containing 7.5% acrylamide in the phosphate buffer 
system of [ 1 l] or in 12.5% acrylamide slab gels using 
the Tris-glycine system of [ 121. 
During inactivation, bands 1 (El) and 4 (E2) of the 
SDS gel pattern disappeared (fig.2). The main product 
resulting from El cleavage was a 94 000 M, fragment 
(band 1 A) which, hence, was only -2% smaller than 
the uncleaved El chain and evidently retained the 
total El activity (fig.1). The E2 polypeptide chain, in 
contrast, apparently was cleaved about in the middle 
to give fragments with app. M, 29 500 (band 4A) and 
27 000 (band 4B). Band 4A, in most cases, was stained 
only faintly with Coomassie blue and was not always 
detectable. With PDC inactivase, papain or elastase, 
cleavage of E2 was faster than El fragmentation. In 
contrast, during treatment with trypsin or bromelain, 
the El band was cleaved faster than E2. 
3. Results 3.2. Disassembly of OGDC after protease treatment 
3 .l. Inactivation of OGDC by proteases 
In a way quite similar to bovine PDC [3,4,7] the 
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Just as with bovine kidney PDC [3,4,7] OGDC 
was disassembled into its enzyme components during 
treatment with papain or elastase. This is demonstrated 
in fig.3 showing the results of sucrose density gradient 
centrifugation of papain-treated OGDC. Whereas E2 
activity sedimented to the bottom of the gradient, El 
(Mr216000[2])andE3(Mr 108000[2])werefound 
in the middle and top fractions. With OGDC treated 
with papain in the presence of the protease-inhibitor 
leupeptin, OGDC overall as well as El, E2 and E3 ac- 
tivities were found together at the bottom of the gra- 
dient. The result in fig.3 furthermore proves that lim- 
ited proteolysis does not affect the association of the 
E2 subunits to give the high M, core structure. The 
SDS gel pattern of some gradient fractions is also 
shown in fig.3 again demonstrating the dissociation 
into the individual enzyme components. Fraction 1 
contains nearly exclusively band 4B characterizing 
this 27 OOOM, fragment as the active domain of E2. 
Fig.2. Fragmentation ofOGDC by papain. OGDC (1.1 mg/ml) 
and papain (1.8 pg/ml) were incubated at 23°C under the 
same conditions as in fig.1. At the times indicated, samples 
were removed, mixed with leupeptin (0.1 mg/ml) and ana- 
lyzed by SDS gel electrophoresis (Tris-glycine system). The 
residual overall activities were: 0 min, 100% (12.5 U/mg); 
5 min, 63%; 10 min, 51%; 15 min, 31%; 30 min, 4.3%. The 
control sample (C, lane 6) contained additionally 80 pg/ml 
leupeptin (residual activity after 30 min, 94%). The extreme 
right lane (M) shows a mixture of marker proteins used for 
Mr estimation [4]. 
Since protease treatment induces the disassembly 
of the enzyme complex into its enzyme components 
these could be isolated, under very mild conditions, 
from papain- or elastase-treated OGDC, by fractional 
precipitation with ammonium sulfate similarly as de- 
scribed for PDC [3,4]. As shown in fig.4, the precipi- 
tate obtained at 36% (NH4)aS04 saturation contained 
both fragments formed from E2 as well as band 2 
which represents a unknown component of kidney 
OGDC [8] and small amounts of E3. The 36-55% 
ammonium sulfate fraction mainly consisted of the 
1.58 
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Fig.3. Sucrose density gradient centrifugation of papain- 
treated OGDC. The complex (3.7 mg/ml) was treated with 
15 pg/ml papain for 15 min at 25°C under the conditions in 
fig.1 (resid. act. 0.03%). The sample was then mixed with 0.1 
mg leupeptin/ml and layered on top of a linear 5-20% gra- 
dient of sucrose in 20 mM potassium phosphate (pH 7.0) 
1 mM MgCl,, 10 PM thiamin diphosphate, 0.1 mM EDTA, in 
the 38 ml tubes of a Beckman SW-27 rotor. Centrifugation 
was carried out at 131 000 X g for 16 h. Fractions of 2 ml 
were collected and analyzed for activity (A). To obtain a 
common scale, the values are plotted as a percentage of the 
total activities. (B) Aliquots of the fractions were mixed with 
an equal volume of double-concentrated sample buffer [ 111 
and used for SDS gel electrophoresis (phosphate system). The 
extreme right gel (C) shows fraction no. 1 of a control experi- 
ment in which the complex was treated with papain in the 
presence of 0.1 mg leupeptin/ml. 
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Fig.4. Fractionation of elastase-treated OGDC with ammonium 
sulfate. OGDC (5.4 mg/ml) was treated with 30 pg elastase/ 
ml at 22°C in 0.1 M potassium phosphate (pH 7.0). After 
15 min, the reaction was stopped by the addition of 34 pg 
elastatinal/ml (overall resid. act. 0.4%). The mixture was then 
diluted to 4 ml (3.7 mg OGDC/ml) and fractionated by the 
addition of appropriate volumes of saturated solution of am- 
monium sulfate in 50 mM potassium phosphate (pH 7.0), 
1 mM MgCl,, 10 PM thiamin diphosphate, 1 mM EDTA, or 
solid ammonium sulfate. Precipitates were collected by cen- 
trifugation (30 min at 35 000 X g) and used for SDS gel elec- 
trophoresis (Tris-glycine system). (A) Untreated OGDC; (B) 
elastase-treated OGDC before fractionation; (C) O-36% am- 
monium sulfate fraction; (D) 36-55% ammonium sulfate 
fraction; (E) 55 -90% ammonium sulfate fraction; (M) marker 
proteins [4]. 
El fragment (band 1A) with only little contamination 
by E3 and a 50 000 Mr fragment probably resulting 
from further cleavage of El. The 59-90s fraction 
contained E3 in a high state of purity (400-570 U/mg). 
4. Discussion 
These results demonstrate that the effect of limited 
proteolysis on bovine kidney OGDC is quite analogous 
to bovine PDC. Various proteases preferentially attack 
the E2 component. The cleavage site, which may 
represent a hinge region between separate folding 
domains, apparently is located near the middle of the 
E2 chain (M, 52 000 in SDS gel electrophoresis) thus 
giving fragments of app. Mr 29 500 and 27 000. The 
latter fragment can be isolated by sucrose density gra- 
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dient centrifugation and contains the active site for 
trans-succinylation as well as the E2 inter-subunit 
binding sites. This is very similar to bovine PDC where 
the E2 component can be cleaved, by a number of 
proteases, into a lipoyl fragment of Mr 28 600 [5] 
and an active fragment ofM, = 26 000 [3-51. How- 
ever, the active OGDCE2 fragment (band 4B) did not 
possess lipoate acetyltransferase activity (not shown). 
PDC-E2 [ 14,151 and its lipoyl fragment [ 51 exhibit 
anomalous migration in SDS gel electrophoresis due 
to the acidic nature and swollen or e,xtended structure 
of the fragment. Although earlier results are suggestive 
of similar anomaly for OGDC-E2 [ 161 this has not 
been clearly established. Thus,Mr of OGDC-E2 as well 
as its lipoyl fragment may have to be corrected. 
Though the enzyme-bound [ 161 lipoyl residues, 
have not been localized in our experiments, it is most 
probable, by analogy with PDC, that the 29 500 Mr 
fragment (band 4A) represents the lipoyl domain of 
OGDC-E2. This domain can be imagined as an exten- 
sion of the lipoyl-lysine flexible arm of the multien- 
zyme complex [ 171. Since lipoyl domains of similar 
size and similar structural properties now have been 
found in the E2 components of Escherichia coli PDC 
[ 171, bovine kidney [4,5] and heart [5] PDC, ,Y. coli 
OGDC [5] and bovine kidney OGDC (this paper), 
this domain structure of the E2 component appears 
to be a general structural principle of the 2-0~0 acid 
dehydrogenase complexes. Thus, the lipoyl domain 
performs the function of an ‘acyl carrier protein’ 
component within the multienzyme complex in a 
similar way as the acyl carrier protein components in 
fatty acid synthetases [ 181 or the carboxyl carrier 
proteins ofbiotin enzymes [ 191 which, in several cases, 
are also linked covalently to other components of the 
enzyme complexes [20,21]. 
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